Using Cannabinoids & Fungus For The Development Of Medicine For Cancer

*** THIS IS A PRESS RELEASE ***
Cannabotech is advancing in the development of botanical medicine for cancer: It reports obtaining a worldwide exclusive license to use a unique fungus for the development and commercialization of products for the treatment of pancreatic and colon cancers

The studied fungus was found effective in killing pancreatic cancer cells and reducing the extent of cancerous tumors in animals; Cannabotech estimates it will present a prototype of the drug as early as the first half of 2023;

Using Cannabinoids & Fungus For The Development Of Medicine For Cancer - Credit PR
Using Cannabinoids & Fungus For The Development Of Medicine For Cancer – Credit PR

Herzliya, Israel – 2 January 2022 – Cannabotech, which develops, among other things, medical cannabis-based products and fungal extracts, reports it received exclusive use of a patent for the development of drugs based on the extract of Cyathus striatus fungus. The fungus is being researched in the laboratory of Professor Fouad Fares, an expert in molecular biology and cancer research at the Faculty of Natural Sciences at the University of Haifa.

According to the agreement signed between Cannabotech and Carmel, the economic company of the University of Haifa, Cannabotech will develop a botanical drug for pancreatic and colon cancers, based on a combination of cannabinoids from the cannabis plant with the fungus extract researched in Professor Fares’ laboratory, which has shown promising results and found to be effective in killing pancreatic and colon cancer cells, and reducing the extent of cancerous tumors in animals, without damaging healthy tissues. 

The THC WEEKLY newsletter, your best source for all things cannabis

Dr. Alex Weissman, an expert in organic chemistry and former director of R&D at the Chimagis Active Ingredients Factory (API), and Dr. Isaac Angel, an expert pharmacologist with more than 15 years of experience in leading drug development processes, will assist Cannabotech in the research process.

A few days ago, Cannabotech reported the results of a study according to which its CannaboBreast product for the treatment of breast cancer, based on a unique combination of cannabinoids and terpenes from the cannabis plant, combined with standard chemotherapy, resulted in an improvement of up to 6-fold in the killing of cancer cells compared to existing treatment (from 10% to 60% cancer cell mortality). 

Cannabotech CEO Elhanan Shaked said: “Cannabotech continues to advance according to its business plan. Along with our preventative medicine products that are already available today, we are operating in the medium-long term in a variety of clinical trials, the most significant of which is the development of a botanical drug for cancer-based on a unique combination of cannabinoids with the Cyathus striatus fungus.”

 Cannabotech CEO Elhanan Shaked - Credit: PR
Cannabotech CEO Elhanan Shaked Credit: PR

Professor Fouad Fares said: “We are pleased with the results achieved so far in animals and the critical reduction in the extent of cancerous tumors and with improved cancer cells’ mortality. The collaboration with Cannabotech enables us to accelerate the research and development process.”

 About Cannabotech:  

Cannabotech is an Israeli biomedical company that develops botanical solutions for preventive medicine and integrative medicine.  These solutions are based on combinations of active agents from the cannabis plant and fungi that work on two central systems in the human body: the endocannabinoid system and the immune system.

As part of the concept of integrative medicine, in the last two years, Cannabotech has been developing a series of 8 preparations based on unique combinations of botanicals from medical cannabis and fungus-based products, designed to help patients with cancer and chronic pain.  Upon completion of their development, the company’s goal is to designate the products to be integrated into oncology patients’ existing treatment protocol.   

At the same time, Cannabotech is working to develop a defined treatment protocol made available to physicians and technology for treatment customization. 

*** END OF PRESS RELEASE **

We would like to remind you that by subscribing to the THE WEEKLY newsletter you are the first to learn about new and exciting cannabinoid. Subscribe today and get our exclusive discounts on Delta 8, Delta 9, Delta 10 THC, THC-P, THC-O, HHC, THCV and other hemp-derived THC products.

Subscribe below to get your 25% discount code

The post Using Cannabinoids & Fungus For The Development Of Medicine For Cancer appeared first on CBD Testers.

Five Things to Know Before Using Cannabis as Alternative Medicine

Cannabis as alternative medicine continues to gain popularity. Although it’s still argued there is not enough large-scale research to prove the effectiveness of cannabis as medicine, plenty of anecdotal evidence shows otherwise. Chances are if you have a medical concern, positive testimonials from friends and family have you searching the web for “weed delivery near […]

The post Five Things to Know Before Using Cannabis as Alternative Medicine appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Weed Wordsearch – Cannabis Edibles

Today’s Weed Wordsearch is all about cannabis edibles! Don’t be fooled, its not as easy as it seems. Fire up a doobie and get ready for a quest! To embark upon it, search for the words listed below the puzzle.  When you find a word: Click on the first and last letter to cross it […]

The post Weed Wordsearch – Cannabis Edibles appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Monday, February 24, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Monday, February 24, 2020 | Curated by host Shea Gunther

// Elizabeth Warren Has A New Plan For Legalizing Marijuana (Marijuana Moment)

// Licensing appeals overwhelm Missouri’s medical marijuana program, point to widespread MJ industry concern about scoring fairness (Marijuana Business Daily)

// Vape crisis forced cannabis sector to increase focus on technology, testing, and transparency (Marijuana Business Daily)


These headlines are brought to you by Green Worx Consults, a company specializing in project management, workflow mapping and design, and Lean & 6 Sigma process. If you could use help making your business better at business, get in touch with Green Worx Consults.


// House Candidate Gives Marijuana To Voters At ‘First-Ever Congressional Weed Party’ (Marijuana Moment)

// Guidance issued for advertising marijuana products in Maine (Portland Press Herald)

// Legal Pot Sales in Canada Rise 8% in December (Motley Fool)

// Reynolds says she’s comfortable with board recs on medical marijuana (Radio Iowa)

// Secret U.S. document shows Canadians who use legal cannabis ‘not eligible’ for Nexus program (Growth Op)

// Medical Schools Aren’t Teaching Their Students About Cannabis, Survey Finds (Merry Jane)

// Federal Reserve Sends Reminder That Hemp Businesses Can Get Bank Accounts (Marijuana Moment)


Check out our other projects:
Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Gage Skidmore/Flickr

VCBC gets raided by the CSU, reopens next day

On July 15, 2020, the Community Safety Unit (CSU) raided the Victoria Cannabis Buyers Club (VCBC), seizing the Cannabis medicine it’s members depend on. Tasked with enforcing the BC Cannabis Control and Licensing Act, The CSU raided the VCBC last November. Despite the fact that we are in the midst of a pandemic and cannabis […]

The post VCBC gets raided by the CSU, reopens next day appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

How to say popular weed words and phrases in sign language

Have you ever wondered how to say popular weed words and phrases in sign language? If so, you are not the first! Thankfully, the American Sign Language is way ahead of us and has created a number of signs for the stoner community. This is awesome news for everyone! For those who sign regularly and […]

The post How to say popular weed words and phrases in sign language appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Monday, February 24, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Monday, February 24, 2020 | Curated by host Shea Gunther

// Elizabeth Warren Has A New Plan For Legalizing Marijuana (Marijuana Moment)

// Licensing appeals overwhelm Missouri’s medical marijuana program, point to widespread MJ industry concern about scoring fairness (Marijuana Business Daily)

// Vape crisis forced cannabis sector to increase focus on technology, testing, and transparency (Marijuana Business Daily)


These headlines are brought to you by Green Worx Consults, a company specializing in project management, workflow mapping and design, and Lean & 6 Sigma process. If you could use help making your business better at business, get in touch with Green Worx Consults.


// House Candidate Gives Marijuana To Voters At ‘First-Ever Congressional Weed Party’ (Marijuana Moment)

// Guidance issued for advertising marijuana products in Maine (Portland Press Herald)

// Legal Pot Sales in Canada Rise 8% in December (Motley Fool)

// Reynolds says she’s comfortable with board recs on medical marijuana (Radio Iowa)

// Secret U.S. document shows Canadians who use legal cannabis ‘not eligible’ for Nexus program (Growth Op)

// Medical Schools Aren’t Teaching Their Students About Cannabis, Survey Finds (Merry Jane)

// Federal Reserve Sends Reminder That Hemp Businesses Can Get Bank Accounts (Marijuana Moment)


Check out our other projects:
Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Gage Skidmore/Flickr

PTSD-Related Suicides Among Veterans Are Rising. Experts Believe Cannabis Can Help.

Numerous organizations, parks, and college campuses across the country have announced they will display 22 U.S. flags this year for Veteran’s Day. Thousands will take up the 22 Push-Up Challenge or hang 22 dog tags on Witting Trees, named for the definition of witting: a purposeful act to emphasize awareness. In this case, people are raising awareness about the fact that an estimated 22 veterans per day commit suicide. 

The Department of Veterans Affairs (VA) released a report on Sept. 20, 2019, confirming that at least 60,000 veterans had died by suicide between 2008 and 2017. The tide of veteran suicides rose nearly 50% during that period and has increased over four of the last five years on record, with an annual average of 7,300 veterans taking their own lives. A National Institutes of Health study confirmed that the most common medical problems facing military veterans today are post-traumatic stress disorder (PTSD), depression, and suicide. Veterans kill themselves at a rate of 22% greater than the general population.

In the 2019 report, the VA says that reducing veteran suicide is a top priority, but some ask why the agency is not looking more closely at one of the most obvious viable solutions: cannabis.

“We know that suicide is related to untreated or undertreated (PTSD),” said Dr. Sue Sisley, principal investigator at the Scottsdale Research Institute (SRI) where she and her colleagues are undertaking the first randomized controlled clinical trials in the world to examine the safety and efficacy of smoked whole-plant cannabis flower to treat PTSD. “We also know that cannabis is helping veterans deal with the symptoms of PTSD, so we owe it to them and their families to study it rigorously regardless of the onerous barriers.”  

Though Sisley and her team’s PTSD studies are functioning with approval of the Food and Drug Administration (FDA), the Drug Enforcement Agency (DEA) and the U.S. Public Health Service (PHS), they still face obstacles, most notably from the VA, the organization dedicated to helping veterans.

“Our government-approved studies with veterans and cannabis may have helped uncover a new treatment for people with PTSD, yet the VA refuses to cooperate with our trials,” Sisley said. 

Researchers are asking the VA to help with cannabis research. The VA isn’t answering the call. 

Robert Kowalski, president and founder of Ohio-based Veterans Ending the Stigma (VETS), believes that the VA’s healthcare system is failing the veterans who need medical cannabis.

“The VA has the resources and ability to answer and supply the data and research needed to include cannabis in modern medicine,” Kowalski told Weedmaps News. “But the reality is that politics and personal views are still prohibiting this to move forward and our veterans are suffering because of it.”

Despite the FDA’s approval of the PTSD trials, the VA continues to treat marijuana as a Schedule I controlled substance. So long as that federal classification exists, the VA cannot recommend or prescribe it. VA healthcare providers and other employees are also prohibited from advocating or helping veterans obtain medical cannabis.

Nevertheless, according to Sisley, they still try. Sisley told Weedmaps News that VA doctors, nurses, and physical therapists covertly call the SRI team asking how they can get patients into their PTSD study. Sisley called the VA’s reluctance to work with SRI shameful and the ultimate hypocrisy.

(Megan Betteridge/Shutterstock)
PTSD-related suicides have been on the rise among veterans. Researchers have approval from the Food and Drug Administration, the Drug Enforcement Agency, and the U.S. Public Health Service to study whether cannabis may be a treatment for people with PTSD, but the Department of Veterans Affairs refuses to assist the study. (Megan Betteridge/Shutterstock)

“The VA is always saying ‘We need more research, we need more rigorous trials looking at cannabis,’ which is exactly what we’re doing…the VA has a golden opportunity to cooperate with us,” Sisley said.

It’s not as though combat veterans haven’t been using cannabis to help with PTSD already. Many who do find that it works and feel the need to share it with the world, Sisley said. Aaron Augustis is one of those veterans. Augustis was a U.S. Army sergeant who served in a combat role in Iraq in 2003. When he returned home, he almost immediately began experiencing PTSD symptoms.

“I started having uncontrollable waves of emotion that would come on suddenly. When you return home from a war, bottled up emotions can be triggered by lots of different things,” Augustis said. “Hearing about soldiers being killed is a common trigger for combat vets, even the smell of diesel fuel can take you back.” 

Augustis said cannabis helped him and many other veterans he knows treat PTSD symptoms, which eventually propelled him to co-found the Veterans Cannabis Group (VCG). The California-based organization provides a safe space for veterans to learn more about managing their PTSD symptoms and other health issues.

One of the issues veterans have been concerned about in recent years, Augustis said, was whether their VA benefits would be taken from them if they tested positive for marijuana. Augustis stressed that the VA no longer penalizes veterans who test positive for cannabis if they live in a state with legal medical marijuana or adult-use laws. 

There are many obstacles when it comes to cannabis research. 

Despite the blessing from various government agencies, Sisley’s PTSD study still faces obstacles, not the least of which is access to acceptable research cannabis. 

Since 1968, the National Institute on Drug Abuse (NIDA) has been the only legal source for federally sanctioned research marijuana, which is grown at the University of Mississippi.

Sisley and other researchers have complained that Ole Miss’s cannabis is poor quality, sometimes moldy and its THC and cannabidiol (CBD) levels are less potent than strains available in dispensaries. With different strains all mixed together, including stems and leaves, Sisley explained that the natural elements found in cannabis flowers cannot be properly isolated, ultimately affecting the correlations between strain and medicinal effect. This, she said, compromises the study’s results.

Sisley went to court in June 2019 and petitioned the Attorney General to order the DEA to process the SRI’s application, and others, that will allow them to grow their own research cannabis. In a lawsuit, the SRI argued that the DEA was stalling on cultivation applications from universities and research institutions, 33 in all, therefore hampering scientific studies.

It has been over three years since the DEA announced it intended to expand its cannabis cultivation process to include additional producers. Alas, the federal court dismissed the SRI’s case on October 18, 2019, arguing that the DEA had fulfilled its requirements. Sisley and her colleagues at SRI are not happy but they’re not giving up. 

“By delaying these 33 applications, the administration has prevented our U.S. scientists from investigating the clinical efficacy of real-world cannabis to treat combat veterans with PTSD,” Sisley said.

But not all is lost. The decision allows Sisley and her team to return to court for additional relief if, she added, “Trump’s DOJ/DEA continues to violate the law and put public health at risk through delay or otherwise.”

Feature image by Sergei Prokhorov/Shutterstock. 

The post PTSD-Related Suicides Among Veterans Are Rising. Experts Believe Cannabis Can Help. appeared first on Weedmaps News.

Researchers Study How to Treat Cannabis Addiction With More Cannabis

The solution to cannabis dependency might simply be more cannabis. That’s according to a new study from researchers at University College London, which found that cannabidiol (CBD) can help people reduce their consumption of THC. Presenting the study at this year’s London’s New Scientist Live festival, lead author Val Curran called the findings “really remarkable.” Curran, a professor of psychopharmacology at University College London, and her team were the first to test the idea of using CBD extracts to treat cannabis use disorders. And indeed, the results are very promising: Curran’s study found that CBD extracts cut the amount of cannabis people smoked in half.

CBD Extracts Can Help Reduce Cannabis Dependency

Cannabis “addiction” can be difficult to define. With no strong chemical dependencies, cannabis use disorders aren’t as destructive or difficult to overcome as those involving more addictive substances, such as nicotine and alcohol. Still, rough estimates put about ten percent of cannabis users in the “addiction” camp. For these cannabis consumers, reducing intake or trying to quit can lead to withdrawal symptoms, including anxiety, insomnia and agitation. Scientists believe increasingly potent THC products are increasing the number of people becoming addicted to cannabis or struggling with dependency issues.

But Curran thinks her research is pointing to an answer. And the answer, she says, is treating cannabis addiction with more cannabis. But Curran doesn’t mean more flower, edibles, concentrates or other THC-dominant products. Instead, she says therapeutic doses of another cannabis compound, cannabidiol (CBD), can help people quit or reduce cannabis use without withdrawal symptoms.

Curran’s study took 82 people living in the U.K. who were classified as “severely addicted” to cannabis. The participants were divided into three groups, and over the course of a four-week trial, each group was given either a daily 400 mg dose of CBD, 800 mg of CBD, or a placebo. All participants also had access to counselors and other psychological support to help them drop their cannabis habit.

According to the study, the 400 mg CBD group experienced the greatest reduction in cannabis use after six months. Researchers measured cannabis consumption by testing participants’ urine for THC. Not only did the 400 mg CBD group have half as much THC in their urine, they also doubled the days when their urine did not test positive for THC. The 800 mg CBD group saw some improvement, but less than the 400 mg group. The placebo group saw no reduction in cannabis consumption.

Cannabidiol (CBD) and the Fight Against Addiction

Curran’s University College London study resonates with other recent findings about the ability of cannabidiol to both counteract the negative side effects of THC and fight addiction. One recent study, published in the Journal of Neuroscience, found that CBD prevents the brain from amplifying stressful stimuli. THC, say researchers, sparks off a chain reaction of nerve signals in the brain that can spiral into stress and anxiety. Cannabidiol counteracts the runaway-train effect, blocking the signaling pathway and preventing the unwanted mental disturbances that potent doses of THC can cause. “CBD gets rid of the toxic effects of THC,” Curran said during her “Cannabis: medicine or madness?” talk at the New Scientist Live festival.

“CBD has a variety of anti-addictive properties,” said University of Sydney professor Iain McGregor. McGregor worked on Curran’s study and is also researching the use of CBD to treat alcohol addiction. Anxiety is a major side effect of detoxifying, and McGregor says CBD is very good at reducing anxiety.

These important studies continue to highlight the wide-ranging therapeutic and health benefits of cannabidiol. But it’s important to keep in mind that most of the commercial CBD products available today, especially outside legal cannabis markets, do not have the potency of the capsules used in Curran’s study. And in most places, CBD products face little if any regulatory scrutiny.

The post Researchers Study How to Treat Cannabis Addiction With More Cannabis appeared first on High Times.